- Home
- SR vs KNSA Comparison
SR vs KNSA Comparison
Compare SR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SR | KNSA |
|---|---|---|
| Founded | 1857 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.9B |
| IPO Year | 2000 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SR | KNSA |
|---|---|---|
| Price | $85.72 | $72.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | $91.40 | ★ $98.00 |
| AVG Volume (30 Days) | 399.4K | ★ 530.1K |
| Earning Date | 11-17-2026 | 10-27-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | 4.30 | ★ 225.00 |
| EPS | ★ 6.14 | 0.27 |
| Revenue | N/A | ★ $677,564,000.00 |
| Revenue This Year | $2.28 | $47.02 |
| Revenue Next Year | $16.55 | $22.84 |
| P/E Ratio | ★ $13.91 | $286.80 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $74.84 | $35.53 |
| 52 Week High | $95.31 | $84.06 |
Technical Indicators
Market Signals| Indicator | SR | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 71.64 | 36.40 |
| Support Level | $84.28 | $43.24 |
| Resistance Level | $88.05 | $81.42 |
| Average True Range (ATR) | 1.44 | 3.30 |
| MACD | 0.84 | -0.49 |
| Stochastic Oscillator | 97.87 | 7.99 |
Price Performance
Historical ComparisonAbout SR Spire Inc.
Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.